Influence of a dominant cryptic epitope on autoimmune T cell tolerance

被引:80
作者
Anderton, SM
Viner, NJ
Matharu, P
Lowrey, PA
Wraith, DC
机构
[1] Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland
[2] Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1038/ni756
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The rules governing which T cells are inactivated during peptide-induced tolerance are unclear. Here we show that MBP(89-101) contains three overlapping but distinct T cell epitopes that are restricted by a single major histocompatibility complex (MHC) class II molecule. The dominant epitope is not processed from MBP and is not relevant to the induction of autoimmunity. Pathogenic T cells recognize two minor epitopes that are processed from MBP but are presented only poorly after exposure to MBP(89-101). Induction of immunological tolerance by MBP(89-101) therefore inactivates T cells that recognize the dominant epitope and disease-relevant T cells escape tolerance. The topology of the three epitopes implicates asparagine endopeptidase as the enzyme that controls recognition of this region of MBP. Our results highlight the need to use peptides that mimic the binding of processed antigen fragments to MHC molecules for successful modulation of disease-relevant T cells.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
[1]  
Anderton SM, 1998, J IMMUNOL, V161, P3357
[2]   ACTIVATION OF T-CELLS RECOGNIZING SELF 60-KD HEAT-SHOCK PROTEIN CAN PROTECT AGAINST EXPERIMENTAL ARTHRITIS [J].
ANDERTON, SM ;
VANDERZEE, R ;
PRAKKEN, B ;
NOORDZIJ, A ;
VANEDEN, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :943-952
[3]  
Anderton SM, 1998, EUR J IMMUNOL, V28, P1251, DOI 10.1002/(SICI)1521-4141(199804)28:04<1251::AID-IMMU1251>3.0.CO
[4]  
2-O
[5]  
Anderton SM, 1999, EUR J IMMUNOL, V29, P1850, DOI 10.1002/(SICI)1521-4141(199906)29:06<1850::AID-IMMU1850>3.0.CO
[6]  
2-N
[7]   Control of antigen presentation by a single protease cleavage site [J].
Antoniou, AN ;
Blackwood, SL ;
Mazzeo, D ;
Watts, C .
IMMUNITY, 2000, 12 (04) :391-398
[8]   Characterization of a recombinant murine 18.5-kDa myelin basic protein [J].
Bates, IR ;
Matharu, P ;
Ishiyama, N ;
Rochon, D ;
Wood, DD ;
Polverini, E ;
Moscarello, MA ;
Viner, NJ ;
Harauz, G .
PROTEIN EXPRESSION AND PURIFICATION, 2000, 20 (02) :285-299
[9]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[10]   DIVERSITY OF ENDOGENOUS EPITOPES BOUND TO MHC CLASS-II MOLECULES LIMITED BY INVARIANT CHAIN [J].
BODMER, H ;
VIVILLE, S ;
BENOIST, C ;
MATHIS, D .
SCIENCE, 1994, 263 (5151) :1284-1286